Elevated levels of TL1A are associated with disease activity in patients with systemic sclerosis.

about

Elevated levels of TL1A are associated with disease activity in patients with systemic sclerosis.

Item

http://www.wikidata.org/entity/Q50736502

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Elevated levels of TL1A are as ...... ients with systemic sclerosis.

@en

Elevated levels of TL1A are as ...... ients with systemic sclerosis.

@nl

type

Item

label

Elevated levels of TL1A are as ...... ients with systemic sclerosis.

@en

Elevated levels of TL1A are as ...... ients with systemic sclerosis.

@nl

prefLabel

Elevated levels of TL1A are as ...... ients with systemic sclerosis.

@en

Elevated levels of TL1A are as ...... ients with systemic sclerosis.

@nl

P1476

Elevated levels of TL1A are as ...... ients with systemic sclerosis.

@en

P2093

Feng Ma

http://www.w3.org/2001/XMLSchema#string

Linchong Su

http://www.w3.org/2001/XMLSchema#string

Pingying Qing

http://www.w3.org/2001/XMLSchema#string

Qiongxiu Zhou

http://www.w3.org/2001/XMLSchema#string

Wangdong Xu

http://www.w3.org/2001/XMLSchema#string

Yan Liang

http://www.w3.org/2001/XMLSchema#string

Yi Liu

http://www.w3.org/2001/XMLSchema#string

Yi Zhao

http://www.w3.org/2001/XMLSchema#string

Ying Wang

http://www.w3.org/2001/XMLSchema#string

P2860

TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator

The 1982 revised criteria for the classification of systemic lupus erythematosus

The TNF-like protein 1A-death receptor 3 pathway promotes macrophage foam cell formation in vitro.

Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-gamma, in mucosal inflammation.

The TNF-family cytokine TL1A inhibits proliferation of human activated B cells

Serum amyloid A is a marker for pulmonary involvement in systemic sclerosis.

TL1A increases expression of CD25, LFA-1, CD134 and CD154, and induces IL-22 and GM-CSF production from effector CD4 T-cells.

European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes.

European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria.

The assessment of the patient with systemic sclerosis.

P304

1317-1324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10067-017-3612-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28397078

http://www.w3.org/2001/XMLSchema#string